Document

0000912061-19-000061.txt : 20190807 0000912061-19-000061.hdr.sgml : 20190807 20190807095850 ACCESSION NUMBER: 0000912061-19-000061 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20190807 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190807 DATE AS OF CHANGE: 20190807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATURAL HEALTH TRENDS CORP CENTRAL INDEX KEY: 0000912061 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190] IRS NUMBER: 592705336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36849 FILM NUMBER: 191004155 BUSINESS ADDRESS: STREET 1: UNITS 1205-07, 12F, MIRA PLACE TOWER A STREET 2: 132 NATHAN ROAD, TSIMSHATSUI, KOWLOON CITY: HONG KONG STATE: K3 ZIP: 00000 BUSINESS PHONE: 852-3107-0800 MAIL ADDRESS: STREET 1: UNITS 1205-07, 12F, MIRA PLACE TOWER A STREET 2: 132 NATHAN ROAD, TSIMSHATSUI, KOWLOON CITY: HONG KONG STATE: K3 ZIP: 00000 8-K 1 nhtc20190630_8k.htm 8-K Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934



	August 7, 2019
Date of Report (Date of earliest event reported)

NATURAL HEALTH TRENDS CORP.

(Exact name of registrant as specified in its charter)



Delaware	001-36849	59-2705336
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

Units 1205-07, 12F, Mira Place Tower A, 132 Nathan Road, Tsimshatsui, Kowloon, Hong Kong

(Address of principal executive offices, including zip code)

+852-3107-0800

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐ Emerging growth company

o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Securities registered pursuant to Section 12(b) of the Exchange Act:



Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	NHTC	The NASDAQ Stock Market LLC

Item 2.02 Results of Operations and Financial Condition.

On August 7, 2019, Natural Health Trends Corp. issued an earnings release announcing its results for the quarter ended June 30, 2019. The press release is attached hereto as exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.


(d)	Exhibits.

99.1 Press Release of Natural Health Trends Corp. dated August 7, 2019

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 7, 2019



	NATURAL HEALTH TRENDS CORP.


	By:	/s/ Timothy S. Davidson
		Timothy S. Davidson
		Senior Vice President and Chief Financial Officer

EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit

Exhibit 99.1

Natural Health Trends Reports Second Quarter 2019 Financial Results


–	Revenue of $23.4 million, a 21% increase compared to the first quarter of 2019


–	Net income of $0.4 million


–	Repurchased $6.7 million of common stock

HONG KONG – August 7, 2019 – Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the second quarter ended June 30, 2019.

Second Quarter 2019 Financial Highlights


•	Revenue of $23.4 million decreased 54% compared to $50.9 million in the second quarter of 2018 and increased 21% compared to $19.3 million in the first quarter of 2019.


•	Gross profit was $18.0 million compared to $40.5 million in the second quarter of 2018, and $14.1 million in the first quarter of 2019. As a percent of total revenue, gross profit was 77% compared to 80% in the second quarter of 2018 and 73% in the first quarter of 2019.


•	Operating loss was $4,000 compared to operating income of $10.1 million in the second quarter of 2018, and operating loss of $2.7 million in the first quarter of 2019.


•	Net income was $397,000, or $0.04 per diluted share, compared to $9.0 million, or $0.80 per diluted share, in the second quarter of 2018, and a net loss of $1.9 million, or $0.17 per diluted share, in the first quarter of 2019.


•	The number of Active Members¹ decreased 10% to 78,280 at June 30, 2019, compared to 87,340 at March 31, 2019, and decreased 16% compared to 93,000 at June 30, 2018.


¹	Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period.

Year-to-Date 2019 Financial Highlights


•	Revenue of $42.8 million decreased 59% compared to $103.3 million in the first six months of 2018.


•	Gross profit was $32.1 million compared to $82.7 million in the first six months of 2018. As a percent of total revenue, gross profit was 75% compared to 80% in the first six months of 2018.


•	Operating loss was $2.7 million compared to operating income of $20.2 million in the first six months of 2018.


•	Net loss was $1.5 million, or $0.14 per diluted share, compared to net income of $17.8 million, or $1.58 per diluted share, in the first six months of 2018.

Management Commentary

“While we continued to face challenges in China that placed significant pressure on our top-line, we were pleased with the high level of commitment shown by our members through the difficult operating environment,” commented Chris Sharng, President of Natural Health Trends Corp. “As a result, our second quarter revenue was up 21% compared to the first quarter of 2019. Though the Chinese government’s 100-day campaign expired in late April, there has been no official conclusion to formally end the program. As such, we continued our voluntary suspension of member activities in China through the entirety of the second quarter as our cooperation with the Chinese government is a top priority. We continue to believe this proactive approach is the best way to position our company for longer-term success and support the actions taken by the Chinese government to protect Chinese consumers.”

Mr. Sharng further commented, “We are encouraged by our progress in other key markets, especially Latin America, led by Peru; Southeast Asia; India and Europe. Further, we deployed several different promotions throughout the quarter to encourage product purchases which were very well received by our members.”

Balance Sheet and Cash Flow

•

Net cash used in operating activities was $3.7 million, including a $1.7 million installment payment on tax payables arising from the 2016 Tax Reform Act effect, compared to $11.4 million in the first quarter of 2019, and net cash provided by operating activities of $5.3 million in the second quarter of 2018. For the first six months of 2019, net cash used in operating activities was $15.1 million, compared to net cash provided by operating activities of $16.5 million in the first six months of 2018.


•	Total cash and cash equivalents were $108.1 million as of June 30, 2019, down from $132.7 million as of December 31, 2018.


•	The Company repurchased 612,729 shares of its common stock at an average price of $10.90 for a total of $6.7 million during the second quarter of 2019. As of June 30, 2019, $25.3 million of the stock repurchase program remained available for future purchases, inclusive of related estimated income tax.

Second Quarter 2019 Financial Results Conference Call

Management will host a conference call to discuss the second quarter 2019 financial results today, Wednesday, August 7, 2019 at 11:30 a.m. Eastern Time. The conference call details are as follows:



Date:	Wednesday, August 7, 2019
Time:	11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time
Dial-in:	1-877-407-0789 (Domestic) 1-201-689-8562 (International)
Conference ID:	13691790
Webcast:	http://public.viavid.com/index.php?id=134956

For those unable to participate during the live broadcast, a replay of the call will also be available from 2:30 p.m. Eastern Time on August 7, 2019 through 11:59 p.m. Eastern Time on August 21, 2019 by dialing 1-844-512-2921 (domestic) and 1-412-317-6671 (international) and referencing the replay pin number: 13691790.

About Natural Health Trends Corp.

Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.

Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on April 26, 2019 with the Securities and Exchange Commission. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

CONTACTS:

Company Contact:

Scott Davidson

Senior Vice President and Chief Financial Officer

Natural Health Trends Corp.

Tel (Hong Kong): +852-3107-0800

Tel (U.S.): 310-541-0888

scott.davidson@nhtglobal.com

Investor Contact:

ADDO Investor Relations

Tel: 310-829-5400

investor.relations@nhtglobal.com

NATURAL HEALTH TRENDS CORP.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)



	June 30, 2019			December 31, 2018
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	108,106		$	132,653
Inventories	10,343			12,165
Other current assets	6,127			5,369
Total current assets	124,576			150,187
Property and equipment, net	887			934
Operating lease right-of-use assets	3,796			—
Goodwill	1,764			1,764
Restricted cash	3,000			2,998
Deferred tax asset	1,210			1,207
Other assets	858			831
Total assets	$	136,091		$	157,921
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	675		$	1,631
Accrued commissions	7,051			12,502
Other accrued expenses	3,676			6,121
Deferred revenue	3,390			6,795
Amounts held in eWallets	13,879			14,611
Operating lease liabilities	1,741			—
Other current liabilities	1,116			1,424
Total current liabilities	31,528			43,084
Income taxes payable	15,365			16,982
Deferred tax liability	187			186
Long-term incentive	7,531			7,808
Operating lease liabilities	2,128			—
Total liabilities	56,739			68,060
Stockholders’ equity:
Preferred stock	—			—
Common stock	13			13
Additional paid-in capital	86,249			86,415
Retained earnings	40,169			44,431
Accumulated other comprehensive loss	(1,192		)	(1,250		)
Treasury stock, at cost	(45,887		)	(39,748		)
Total stockholders’ equity	79,352			89,861
Total liabilities and stockholders’ equity	$	136,091		$	157,921

NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(In thousands, except per share data)



	Three Months Ended June 30,					Six Months Ended June 30,
	2019			2018		2019			2018
Net sales	$	23,428		$	50,910	$	42,756		$	103,277
Cost of sales	5,407			10,399		10,631			20,620
Gross profit	18,021			40,511		32,125			82,657
Operating expenses:
Commissions expense	11,398			22,310		20,896			45,290
Selling, general and administrative expenses	6,627			8,093		13,942			17,215
Total operating expenses	18,025			30,403		34,838			62,505
Income (loss) from operations	(4		)	10,108		(2,713		)	20,152
Other income, net	373			53		805			216
Income (loss) before income taxes	369			10,161		(1,908		)	20,368
Income tax provision (benefit)	(28		)	1,138		(382		)	2,521
Net income (loss)	$	397		$	9,023	$	(1,526	)	$	17,847
Net income (loss) per common share:
Basic	$	0.04		$	0.80	$	(0.14	)	$	1.58
Diluted	$	0.04		$	0.80	$	(0.14	)	$	1.58
Weighted-average number of common shares outstanding:
Basic	11,082			11,298		11,207			11,292
Diluted	11,082			11,305		11,207			11,297

NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(In thousands)



	Six Months Ended June 30,
	2019			2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$	(1,526	)	$	17,847
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	189			235
Noncash lease expense	914			—
Deferred income taxes	(3		)	—
Changes in assets and liabilities:
Inventories	1,881			(2,057		)
Other current assets	(752		)	1,955
Other assets	(35		)	(73		)
Accounts payable	(956		)	1,246
Accrued commissions	(5,475		)	(707		)
Other accrued expenses	(1,946		)	1,119
Deferred revenue	(3,409		)	(592		)
Amounts held in eWallets	(765		)	(192		)
Operating lease liabilities	(964		)	—
Income taxes payable	(1,617		)	(1,657		)
Other current liabilities	(318		)	(72		)
Long-term incentive	(277		)	(562		)
Net cash provided by (used in) operating activities	(15,059		)	16,490
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(141		)	(113		)
Net cash used in investing activities	(141		)	(113		)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repurchase of common stock	(6,682		)	—
Dividends paid	(2,736		)	(23,093		)
Net cash used in financing activities	(9,418		)	(23,093		)
Effect of exchange rates on cash, cash equivalents and restricted cash	73			(381		)
Net decrease in cash, cash equivalents and restricted cash	(24,545		)	(7,097		)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period	135,651			138,478
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period	$	111,106		$	131,381
SUPPLEMENTAL DISCLOSURES OF OTHER CASH FLOW INFORMATION:
Issuance of treasury stock for employee awards, net	$	377		$	554
Right-of-use assets obtained in exchange for operating lease liabilities	$	4,697		$	—

EX-101.SCH 3 nhtc-20190807.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 nhtc-20190807_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 nhtc-20190807_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 nhtc-20190807_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover page. Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, Address Line Three Entity Address, City or Town Entity Address, City or Town Entity Address, Country Entity Address, Country City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag EX-101.PRE 7 nhtc-20190807_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 8 nhtc20190630_8k_htm.xml IDEA: XBRL DOCUMENT 0000912061 2019-08-07 2019-08-07 false 0000912061 8-K 2019-08-07 NATURAL HEALTH TRENDS CORP. DE 001-36849 59-2705336 Units 1205-07, 12F Mira Place Tower A 132 Nathan Road Tsimshatsui HK 852 3107-0800 false false false false false Common Stock, par value $0.001 per share NHTC XML 9 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information	Aug. 07, 2019
Cover page.
Document Type	8-K
Document Period End Date	Aug. 07, 2019
Entity Registrant Name	NATURAL HEALTH TRENDS CORP.
Entity Incorporation, State or Country Code	DE
Entity File Number	001-36849
Entity Tax Identification Number	59-2705336
Entity Address, Address Line One	Units 1205-07, 12F
Entity Address, Address Line Two	Mira Place Tower A
Entity Address, Address Line Three	132 Nathan Road
Entity Address, City or Town	Tsimshatsui
Entity Address, Country	HK
City Area Code	852
Local Phone Number	3107-0800
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	NHTC
Entity Central Index Key	0000912061
Amendment Flag	false

EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( %A/!T\?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ 6$\'3R?HAPZ" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " !83P=/L#Z((O K @ $0 &1O8U!R;W!S+V-O M&ULS9+/3L,P#(=?!>7>.EWYLT5=+B!.("$Q"<0M2KPMHFFBQ*C=VY.6 MK1."!]@Q]B^?/TMN=!#:1WR)/F DB^EJ<&V7A YKMB<* B#I/3J5RISHE/M4-8<'X+#DD910I&8!%F(I.-T4)'5.3C$6_TC ]?L9U@1@.V MZ+"C!%59 9/CQ' 8V@;.@!%&&%WZ*:"9B5/U7^S4 79,#LG.J;[OR[Z>&PO=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&V MM!-S:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X M>?/N+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E M'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ( MX53"Q,!J9S]6:\?1TDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T M;1K@X_%X.+;+THMP' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW? MZYMHG J-6T_3:W?=TXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;C MZWH2%;7E0-,@ %AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6 M-$9RG9 %#@ WQ-%,4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[ MR:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>I MP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^ M",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SCFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ M ?_1VC?"J_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH M9%LE"0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-# MMW)+ZK:4OK4F.$KTL@'37[]EUVY".E,%.70[@:0KX# M;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW' MB/*B(>ZAAIC/PT.'>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$" M\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO* MWF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4" M(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8> M^3+?.7#;.MX#7N83+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@ M#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6: M&C/5BZPYC0IO0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+ MOP%02P,$% @ 6$\'3P3M?=V= @ F L !@ !X;"]W;W)KBT;OX]*8=ILD^ESRFNDGV?+& M?KE*53-CA^J6Z%9Q=NE)M4AHFBZ3FE5-7.SZN:,J=O)N1-7PHXKTO:Z9^GO@ M0G;[F,0?$R_5K31N(BEV+;OQG]S\:H_*CI*IRJ6J>:,KV42*7_?Q)[(]T-P1 M>L1KQ3L]>X_<5DY2OKG!M\L^3MV*N.!GXTHP^WCP9RZ$JV37\6_J8LI]O(ZC"[^RNS OLOO*QPTMXFC<_7?^X,+"W4JL MQED*W?]&Y[LVLAZKV*74['UX5DW_[(8O>3[2< (="?0_8=C+(-2O_#,SK-@I MV45J./R6.8_)EMJS.;O)_BCZ;W;QVLX^BG27/%R9$7$8$'2&(!,BL;4G 8H* MT)Z>S>@4IVOI^8R>>>N#B!P7R%&!'- 7G@!$+'&!!2JP /25)P 1:UQ@ MB0HL 7WC"4 $27&%%:JP@GSB22"0@,]K5&(-^;[1""3@] :5V$"^;S4""7A- M4CQ.*:S@VXUA H:30&@)K.![CF!HP'2")Y=06,&W'<,$?"=XP G,+_6=QS ! MZPF><@)#3'WS,4S(?3SJ!":9 O<13,A]/.\$QID"]R$F"[F/9Y[ 1&? ?003 M4L%C3V"H,^JK()B0"IY\ G.=@3N&8 (J%,\^A;G.!?&^8Z\V\RA@G<9(IGGR+_[OY-1C!YZ,3P[%.8Z]R_R0@&^)+,>BK7 ML_Y@ZE8U.CI)8]NSOHFZ2FFXK9<^V927MDV>!H)?C7M=V7:4$MWNK4,X5F-#$98U;D7D#(P!.4RQ:4DO\IV525TEZW+H/69&SX9&PG M,Q67@DD+H4Q@+BVW1UC*,R57GZHEI*&C* MNO706YKH6+!Z<-2Y;<1OF.:J4I; C%KGU9.>8?O+Q<5[@E[KV;*4&ZLITJVI M<#C68?2P#5>PF(>K: '1=KZ>[6!ZO]TX9;P9%"M=*'VRJ T[B\I :3C9JX]X M39PLLWD#V0W/&:Q+\GW M>H,&IC!)-#.F_?P&VVF94PE;1Y"/":76'_4RA3N<<,UI7H=L-.O$R,QDS,[[S62"/;S?[UV-#GAI M3(G@_[WSZO%<,)U60GYJ=;!954U!I6-UQ"TND]KC7'Y[_ X[%I=8O@.KO,!= MV5D5_V[C@:7AB>8E@Z^DBRL'!8K!EFO'D$C3I!*Q.XI'Y7BQ7D33!OE3K%9C M!Y=8Z#/<,D<1P=\5;M7 =TXX="HYN763T_1?U,/OPN0%4$L#!!0 ( %A/ M!T^ZH3F*UP$ #(& - >&POC"@J"RL.?!U[2=MH'<3*?'=G^]2=/;T0?QX(.^-#/?3+[YGTP!07 MFA:9'M23PIY49M"8TQ-E1=88O2-W- (^E2L@%RYS^LBE*)V8<[D2BF0TR0@_6L,)]$+*A<>);1Q 62Q0OR62_I/@=7KO2NDW 2F- )%9CDB M./WDG3EY!G\)D<4^3]8K;!V?DO2>[A/FP1S'A< MT0G\1[;(?:"]OXF66'$Q^&'PJ]&S_VTP",\.&C'._MAL]3T[MU9.[Z5HM8*X MEM\63&XL6&1\K4,ZX\2KYPLWI?( .$HNX%!41^2[X_8,(ZZW:6QNU9S^AYK_ M]CZWH,%Q>13MK_Z_O,M_HI@MW7-HT:L&W5!2#D*BT(O&3M0U1'GAA_GUM#P0>)S6/$HQ:#> MS@7WOT3Q U!+ P04 " !83P=/,/_DSL^/%T?E]Z=Q>?!EM0R%;HFZ>9:%JP:APY3JPW&F<-XJX]+LL M=!Y4'5H ,CJ;YODL,PJMO%N,6FN?71:.H")TEL$(;!&.X=R/I5!,.,"G*@N9 M2Z%Z3\Z2TIO* M.ZW3J]A(CWA"^$6VX FK/T12Y8=BKX636PZ[ MU_J!L7?[ZE32CQKCQ]W] %!+ P04 " !83P=/_\ F"+T "% @ &@ M 'AL+U]R96QS+W=OE%!H0=%#(\='E\Q4??TEUG/7H(PK8>_R43]-<#JUV5?4$L#!!0 ( M %A/!T\+C]@#(0$ %<$ 3 6T-O;G1E;G1?5'EP97-=+GAM;+5434_# M, S]*U.O:,W@P %MNP!7F 1_("1N&S5?LKW1_7O<;D-B*F)HVR6)\^SW7A(K M\_=M!IITP4=:% US?E"*3 -!4YDR1$&JA$&SA%BKK$VK:U!WL]F],BDR1)YR MSU$LYT]0Z;7GR>-NOZ=>%#IG[XQFEZ+:1'M$.MT3E@A^R*'&9;J1A&+RW D+ MR=ZB$)0*=8+"<6$?2]WK!A"=A7]92U7E#-ADUD%*2LH(VE(#P,&7U&@$^\;H M8KWWN]+(+SH(L>J\^I%07L\';SV,&QB02RJSM 6,20W ;KP]2_#0#28A3#,* MBNQ&CB>65H*2ZA,O>43H6\>"/4E&UL4$L! A0#% M @ 6$\'3P3M?=V= @ F L !@ ( !^0@ 'AL+W=O7!E&UL4$L%!@ * H @ ( !@4 ! $! end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 1 97 1 false 0 0 false 0 false false R1.htm 0001000 - Document - Document And Entity Information Sheet http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports nhtc20190630_8k.htm ex99-1.htm nhtc-20190807.xsd nhtc-20190807_cal.xml nhtc-20190807_def.xml nhtc-20190807_lab.xml nhtc-20190807_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nhtc20190630_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "nhtc-20190807_cal.xml" ] }, "definitionLink": { "local": [ "nhtc-20190807_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "nhtc20190630_8k.htm" ] }, "labelLink": { "local": [ "nhtc-20190807_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "nhtc-20190807_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "nhtc-20190807.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nhtc", "nsuri": "http://www.naturalhealthtrendscorp.com/20190807", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nhtc20190630_8k.htm", "contextRef": "D2019Q3Aug07-Aug07", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Document And Entity Information", "role": "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nhtc20190630_8k.htm", "contextRef": "D2019Q3Aug07-Aug07", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 17 0000912061-19-000061-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000912061-19-000061-xbrl.zip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end